New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). Creative Medical Technology Holdings, Inc. Timothy Warbington, CEO of Creative Medical Technology, said, “The FDA’s clearance and IRB approval allowing us to pursue this clinical trial … Continue reading “Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial”
Author: Sophia Vida
Sofia has been writing for major news outlets for over 15 years. In her spare time she enjoys hiking, walking her dogs, and going to concerts.
Breaking News
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
LOS ANGELES, December 21, 2023 – Clubhouse Media Group, Inc. (OTC: CMGR) (“CMGR”), a social…
December 21, 2023
Breaking News
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%
New York, December 20, 2023 – PRISM MarketView, a leading provider of unbiased market insight…
December 20, 2023
Breaking News
PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success
New York, December 20, 2023 – Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of…
December 20, 2023
Breaking News
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control
Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December…
December 20, 2023
Breaking News
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership
New York, December 20, 2023 – Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more…
December 20, 2023
Breaking News
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
–Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 – Lipella…
December 20, 2023
Breaking News
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 19, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified…
December 19, 2023
Breaking News
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment
New York, December 19, 2023 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its…
December 19, 2023
Breaking News
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
TAMPA, FLORIDA, December 19, 2023 – PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced…
December 19, 2023
Breaking News
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative…
December 19, 2023
Breaking News
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 – Shares in Battalion Oil Corporation (NYSE American: BATL) surged more…
December 18, 2023
Breaking News
MindMed Advances Treatment for Generalized Anxiety Disorder
NEW YORK, NY, December 18, 2023 – Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from…
December 18, 2023
Breaking News
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable…
December 18, 2023